I am a board-certified medical oncologist specializing in the treatment of patients with gastrointestinal (GI) cancers, particularly colorectal cancer (CRC), appendix cancer, and cholangiocarcinoma. My research is focused on the development of novel systemic and regional therapies, including approaches based on tumor genomics, with the goal of improving outcomes while minimizing treatment-related toxicities.   

I am the founder and co-director of the Center for Young Onset Colorectal and Gastrointestinal Cancer. This clinic — the first of its kind in the world — is dedicated solely to the specific needs of people under 50 who have CRC or other GI cancers.